Dr. Wu Skincare Co., Ltd. (TPEX:6523)

Market Cap	5.45B
Revenue (ttm)	1.24B
Net Income (ttm)	403.66M
Shares Out	45.05M
EPS (ttm)	8.92
PE Ratio	13.56
Forward PE	n/a
Dividend	11.00 (9.05%)
Ex-Dividend Date	Dec 4, 2025

Volume	26,400
Average Volume	60,437
Open	120.50
Previous Close	121.50
Day's Range	120.00 - 121.00
52-Week Range	114.00 - 156.00
Beta	0.01
RSI	45.68
Earnings Date	Mar 4, 2026

About Dr. Wu Skincare

Dr. Wu Skincare Co., Ltd. engages in the research, development, production, wholesale, and retail of cosmetics and skincare products in Taiwan and internationally. The company offers collagen peptide powders, cleansers, masks, toners, serums, hydrating lotions/creams/gels, UV/DD creams, and eye care products, as well as makeup and body products. It also provides products for acne and pores, blackheads, dry skin, signs of aging, dull and spotty skin, sensitive skin, whitening, and emergency care. The company was incorporated in 2003 and is based...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 2003
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6523

Financial Performance

In 2024, Dr. Wu Skincare's revenue was 1.24 billion, an increase of 9.20% compared to the previous year's 1.14 billion. Earnings were 476.25 million, an increase of 12.13%.